A number of studies have shown that pancreatic ductal adenocarcinoma develops through precursor lesions termed pancreatic intraepithelial neoplasia (PanIN). PanINs are thought to initiate in the small ducts of the pancreas through activating mutations in the KRAS proto-oncogene. What remains unanswered is the identification of the individual cell type(s) that contributes to pancreatic ductal adenocarcinoma formation. To follow the cellular and molecular changes that occur in acinar and duct cell properties on Kras G12D expression, we took advantage of LSLKras
The development of individual cell types or organ systems progresses through restricted molecular and morphological pathways that ultimately define the endpoint phenotype. In most instances, the terminal differentiation state is static with cells primed to perform a final, highly specialized biological function. However, at times of stress, injury, or genetic alterations, cells are capable of exhibiting remarkable cellular plasticity in which tissues undergo metaplasia. Metaplasia is defined as the process by which one predominant adult cell type is replaced by a different adult cell type. 1, 2 This process occurs through a variety of mechanisms, including activation and expansion of quiescent stem cells with the concomitant removal of the unwanted cell population. 3 Metaplasia can also be achieved through transdifferentiation events in which individual cells are reprogrammed to transition from one differentiated cell type into another. In instances in which this process is relatively slow, biphenotypic cells can be identified that exhibit aspects of each differentiated cell, whereas in cases of rapid conversion identification of biphenotypic cells is elusive. Metaplasia is frequently associated with an increased risk of neoplasia and is often a hallmark of many human cancers.
One cancer that shows metaplastic properties is pancreatic ductal adenocarcinoma (PDA). PDA is the fourth leading cause of cancer deaths in the United States with ϳ213,000 new cases diagnosed world-wide each year.
though clinical progress has been slow, our understanding of the genetic and cellular events that precede PDA formation have been extensive and a common model for the development of PDA has emerged in which clinical, histopathological, and genetic studies have identified precursor lesions and genetic alterations that lead to PDA formation. The most common precursor lesions are known as pancreatic intraepithelial neoplasia (PanIN). [5] [6] [7] PanINs are thought to initiate in the small ducts of the pancreas and are classified from low grade to high grade (PanIN-1, PanIN-2, PanIN-3) based on the relative degree of cellular architecture and nuclear atypia. Molecular profiles for each grade of PanIN have been defined with activating mutations in the KRAS proto-oncogene thought to be early events in the development of PanIN-1 lesions. Additional genetic alterations occur temporally and include telomere shortening (PanIN-1), inactivation of the p16
INK4a locus (PanIN-2), and inactivation of Trp53, SMAD4/DPC4, and occasionally BRCA2 (PanIN-3). [5] [6] [7] These alterations cause pleiotropic effects that are reflected in the deregulation of signaling pathways controlling cell proliferation, survival, adhesion, and migration. 8, 9 What remains unanswered is how these pathways generate unique pathologies within the PanIN and PDA spectrums. Equally important is identifying the individual cell types that contribute to this disease.
To study the initiation and progression events that are responsible for PDA promotion, the endogenous mouse Kras locus has been targeted with a Kras G12D allele (LSLKras G12D ). 10, 11 In this model, the LSL-Kras G12D locus remains transcriptionally inert unless activated by Cre recombinase. Pancreas-specific Cre expression is provided by crossing LSL-Kras G12D/ϩ mice to pdx1-Cre 10 or p48 Cre/ϩ12 mice, which express Cre throughout the developing and adult pancreas. LSL-Kras G12D/ϩ /pdx1-Cre and LSL-Kras G12D/ϩ /p48 Cre/ϩ mice develop PanINs (called mPanIN in the mouse) with 100% penetrance. 10 In all cases, the number and grade of the mPanIN lesions increase (mPanIN-1 3 mPanIN-2 3 mPanIN-3) with advancing age. Animals 2 to 3 months old contain primarily normal ducts (Ͼ80%), whereas the majority of the duct structures in older animals (7 to 10 months) exhibit highgrade mPanIN-3 to rare invasive and metastatic PDA. 10 Inclusion of additional genetic defects leads to more severe and rapid PDA disease. [13] [14] [15] Although there is convincing evidence that PanINs progress to PDA as they accumulate additional genetic alterations, there remains uncertainty as to the contribution of individual cell lineages in this progression scheme. For instance, it is unknown if duct cells are solely responsible for PanIN development or whether additional cell types (acinar, islet, stellate, adult progenitor cells) may contribute to the formation of PanIN-1 lesions. Preliminary data from several groups 13, 15, 16 have shown that Kras G12D -or transforming growth factor (TGF)-␣-induced PanIN structures often exhibit molecular heterogeneity, suggesting that mPanIN cells are not equivalent. Indeed, these initial observations support the concept that more than one pancreatic cell lineage may participate in PanIN formation and ultimately in PDA development.
To investigate the initial changes that occur in acinar and duct cell properties on Kras G12D expression, we took advantage of the LSL-Kras
Cre/ϩ model. Acinar-ductal metaplasia was the predominant alteration observed at 4 weeks in the pancreas. Metaplastic acinar structures were highly proliferative, expressed Notch target genes, and consisted of acinar and duct cell phenotypes. These cells also exhibited mosaic expression patterns for EGF signaling components, in which cells that retained acinar characteristics were epidermal growth factor receptor (EGFR)-and cytoplasmic ErbB2-positive but pErk-negative. In contrast, cells exhibiting a duct cell phenotype expressed high levels of pErk and nuclear ErbB2 but became EGFR-negative. Interestingly, the expression of these signaling intermediates precisely mimicked expression detected in PanIN lesions, suggesting that PanINs and acinar-ductal metaplasia follow similar molecular pathways. Indeed, early mPanIN-1 lesions consisted of both duct and acinar cell types, raising the possibility that Kras G12D -induced PanINs develop from acinar cell lineages that undergo acinar-ductal metaplasia to generate the characteristic ductal phenotype observed in PDA.
Materials and Methods

Mouse Strains
Conditional LSL-Kras 
/p48
Cre/ϩ and LSL-Kras G12D/ϩ / pdx1-Cre mice as previously described. 10 Individual genotypes were confirmed by standard polymerase chain reaction (PCR) conditions using gene-specific primer sets. 10 All studies were conducted in compliance with the National Institutes of Health and the Purdue University Institutional Animal Care and Use Committee guidelines.
Histological Analysis and Immunohistochemistry
Murine tissues were fixed in 10% neutral buffered formalin, embedded in paraffin, and 4-m serial sections prepared. Routine hematoxylin and eosin (H&E) staining was performed by standard procedures. Immunohistochemistry was accomplished with biotinylated secondary antibodies using the Elite Vectastain ABC kit and peroxidase substrate diaminobenzidine kit (Vector Laboratories, Burlingame, CA). Briefly, sections were deparaffinized, rehydrated, and antigens were retrieved using the 2100-Retriever (PickCell Laboratories, Amsterdam, The Netherlands) and antigen unmasking solution (Vector Laboratories). For keratin 19 (K19) immunolabeling, antigen retrieval was done by digesting sections with 250 g/ml proteinase K in 2.5 mmol/L CaCl 2 and 10 mmol/L Tris-HCl, pH 7.5, for 6 minutes at room temperature. Samples were blocked using the MOM blocking reagent (Vector Laboratories). Primary antibodies were incubated at 4°C overnight and included rabbit amylase (1:1000; 
Protein Immunoblot Assays
Whole cell protein extracts (50 g) were separated on 7.5% acrylamide gels, transferred to polyvinylidene difluoride membranes, and incubated with primary antibodies against rabbit amylase (1:5000; Calbiochem), rat K19 (1:500), sheep carbonic anhydrase II (1:500; The Binding Site, Birmingham, UK), EGFR (1:1000, no. 2232; Cell Signaling), rabbit Neu/ErbB2 (1:1000, sc-284; Santa Cruz Biotechnology), and rabbit phospho-ErbBs (1:1000; Cell Signaling) including phospho-EGFR (Tyr845) (no. 2231), phospho-EGFR (Tyr992) (no. 2235), and phospho-Her2/ ErbB2 (Tyr1221/1222) (6B12, no. 2243). Rabbit Hsp 90␣/␤ (1:2000, sc-7947; Santa Cruz Biotechnology) was used as a loading control. After secondary antibody incubation, the immunoblots were developed using an enhanced chemiluminescence kit (Pierce, Rockford, IL) as per the manufacturer's instructions.
RNA Expression Analysis
Total RNA was isolated from the pancreas using the RNeasy isolation system (Qiagen, Valencia, CA). One g of total RNA was reverse-transcribed using the iScript cDNA synthesis kit (Bio-Rad, Hercules, CA). cDNA reactions were amplified with Taq polymerase and gene-specific primers for mouse Hes1 (5Ј-TCTACACCAGCAACA-GTG-3Ј, 5Ј-TCAAACATCTTTGGCATCAC-3Ј), Hey1 (5Ј-GCGGACGAGAATGGAAACTTG-3Ј, 5Ј-GCTCAGATAA-CGGGCAACTTCG-3Ј), and Hey2 (5Ј-TGAGCATTGGAT-TCCGAGAGTG-3Ј, 5Ј-ATACCGACAAGGGTGGGCTGA-TTG-3Ј). Target sequences were amplified within the linear range using 95°C for 40-second, 55°C for 40-second, and 72°C for 55-second conditions.
Results
PanIN in humans is often associated with lobulocentric parenchymal atrophy with three distinct cellular compartments, ducts at the center of lobules with associated PanINs, a zone of acinar-ductal metaplasia, and areas of normal, differentiated acinar cells ( Figure 1A) . 19, 20 The acinar-ductal metaplastic structures contain both acinar (zymogen granules, intense eosinophilic staining) and duct-like cells with a mucinous cytoplasm ( Figure 1B ). Despite these clinical observations, the relationship between PanINs and acinar structures in disease progression remains unclear.
To study the molecular events involved in acinar-ductal metaplasia, we examined the LSL-Kras G12D/ϩ /pdx1-Cre and LSL-Kras G12D/ϩ /p48 Cre/ϩ mouse models. 10, 15 These animals develop ductal lesions (mPanINs) 21 that recapitulate the full spectrum of human PanINs, eventually progressing to rare PDA. As with the human condition, the pancreatic lobules in the Kras G12D/ϩ /pdx1-Cre and LSLKras
Cre/ϩ mice developed three distinct zones of cells consisting of PanINs, acinar-ductal metaplasia, and normal acinar cells ( Figure 1C ). Examination of the mouse acinar-ductal metaplastic units again revealed the presence of acinar cells and duct-like cells within a single structure ( Figure 1D ). Thus, LSL-Kras G12D/ϩ mice faithfully model the human disease and provide an opportunity to identify the earliest events that participate in acinar-ductal metaplasia and mPanIN formation.
Characterization of Acinar-Ductal Metaplastic Structures in LSL-Kras
Cre/ϩ Mice Although PanINs are considered the precursor lesions to PDA, the contribution of acinar cells and acinar-ductal metaplasia to the initial stages of disease progression has not been extensively studied, in part because of the difficulty of following early events in patients. We examined young (4 to 6 weeks) LSL-Kras G12D/ϩ /p48 Cre/ϩ mice to investigate the earliest changes in acinar and duct cell properties that are induced on Kras G12D expression. As expected, wild-type and control LSL-Kras G12D/ϩ pancreata (lacking Cre) contained normal ducts and acinar cells and showed no signs of activation of the Kras G12D allele ( Figure 1E ). LSL-Kras
Cre/ϩ pancreata similarly exhibited large areas of normal acinar and duct cells that were indistinguishable from control animals ( Figure 1F ). Indeed, at this age most ductal epithelium remained normal, comprised solely of cuboidal cells with uniform, round nuclei and amphophilic cytoplasm. mPanIN lesions were rarely observed. However, 4-week LSLKras
Cre/ϩ samples did exhibit significant acinar metaplasia in which individual acini developed distended, open lumens and contained mucin-expressing duct-like cells ( Figure 1 , G and H). The duct-like cells showed a loss of zymogen granules and assumed a columnar appearance with atypical nuclei.
To examine the molecular events that defined the acinar-ductal structures, LSL-Kras
Cre/ϩ tissues were immunolabeled (immunohistochemistry) for amylase (acinar-specific) and K19 (duct-specific). At 4 weeks, individual acini were identified that expressed both amylase and K19 gene products ( Figure 1I ). In many cases, biphenotypic cells coexpressing amylase and K19 were observed. In contrast, normal ducts from wild-type or control LSL-Kras G12D/ϩ mice never contained amylase-positive cells, and normal acinar cells never expressed K19 ( Figure 1J ). The molecular changes from an acinar to ductal phenotype was also observed in older animals (4 months) by immunoblot analysis in which acinar (amylase) gene products decreased and duct (K19, CA II) gene products increased on activation of Kras G12D expression ( Figure 1K ). These results demonstrate that LSL-Kras G12D/ϩ /p48 Cre/ϩ mice undergo a dramatic shift from acinar to ductal cell types on activation of the Kras G12D gene.
Early Acinar Metaplasia Is Associated with Cellular Proliferation, Pdx1 Expression, and Activation of Notch Signaling
The early appearance of acinar metaplasia in LSLKras G12D/ϩ /p48 Cre/ϩ pancreas samples suggested that metaplastic acinar cells participate in disease progression. If true, metaplastic structures should exhibit an elevated cellular proliferation index. To examine this, 4-week control LSL-Kras G12D/ϩ and experimental LSL-
Cre/ϩ pancreata were analyzed for evidence of cellular proliferation. At this age, only 3.7% of acinar cells and 9.7% of duct cells from control LSLKras G12D/ϩ mice expressed the cell proliferation marker Ki67 (Figure 2A ). In LSL-Kras G12D/ϩ /p48 Cre/ϩ mice the proliferation rate of histologically normal acinar and of ductal cells both increased (35.1 and 37.8%) ( Figure 2B ). However, the proliferation indices were highest in the metaplastic acinar structures. For the earliest metaplastic events (open lumens), multiple Ki67-positive acinar cells were always identified (Figure 2 , C and D), whereas only random, single Ki67-positive acinar cells were detected in age-matched control LSL-Kras G12D/ϩ mice. As metaplastic structures grew in size, the percentage of Ki67-positive cells also increased ( Figure 2 , E and F). Similar results were obtained using a phospho-(ser 10 ) histone 3 antibody (data not shown). Interestingly, most proliferating cells within a single structure exhibited a duct cell phenotype whereas the few remaining Ki67-negative cells retained acinar cell characteristics (zymogens) (Figure 2, E and F) . These results suggest that cells within a metaplastic acinus actively divide only after converting to a duct-like cell. 10, 12 only a subset of the cells undergo acinar-ductal metaplasia and exhibit an increased proliferation rate. Differences in specific signaling pathways probably account for some of the observed alterations in the acini. One pathway that has been implicated in pancreatic cancer progression is Notch signaling. Induction of Notch activity is thought to be an initiating event of PanIN formation and pancreatic tumorigenesis, and this pathway may be critical to maintaining transformed cells in an undifferentiated state. 16, [22] [23] [24] [25] Analysis of Notch signaling in LSLKras G12D/ϩ /p48 Cre/ϩ mice revealed that the Notch target genes Hes1, Hey1, and Hey2 were transcriptionally upregulated in the presence of Kras G12D activity ( Figure 3A ). Using immunohistochemistry and antibodies against Hes1 and Mist1 (an acinar-restricted transcription factor), 18, 26 we next examined control LSL-Kras G12D/ϩ and experimental LSL-Kras G12D/ϩ /p48 Cre/ϩ samples to identify the cell types involved in activation of the Notch signaling pathway. As shown in Figure 3 , B and C, Hes1 expression in the control pancreas was restricted to Mist1-negative, centroacinar cells. 16 In contrast, early acinar metaplastic structures from 4-week LSL-
Cre/ϩ mice contained a significant number of Hes1-positive cells (Figure 3, D-F) . In most cases, the differentiated acinar cells (containing zymogen granules) present in these early metaplastic structures remained Hes1-negative, whereas the duct-like cells were Hes1-positive ( Figure 3E ). For slightly larger acinar metaplastic structures, Hes1 protein was also detected in the surrounding acinar cell areas ( Figure 3F 
Finally, Hes1 expression is thought to be instrumental in maintaining transformed cells in an undifferentiated state in which pancreatic cancer precursor lesions often activate expression of embryonic genes such as Pdx1. 10, 16 The PDX1 transcription factor is critical to pancreas development and is initially expressed in the earliest pancreatic cell lineages but becomes restricted to islet ␤-cells in the adult ( Figure 3M) . 12 In LSLKras
Cre/ϩ mice Pdx1 expression was activated in the early acinar metaplastic units as well as in mPanIN lesions, and this activation became more robust as acinar metaplasia progressed (Figure 3, N and O) , again suggesting that both acinar-ductal metaplasia and mPanIN formation require activation of the same transcriptional network.
Activation of Specific EGF Receptor Signaling Pathways Defines Acinar and Ductal Metaplastic Properties
One hallmark of precursor ductal lesions and PDA tumor progression is the activation of specific signaling pathways that ultimately provide growth and survival advantages to the cells. In the case of PDA, the EGF, TGF-␤, and Notch signaling pathways are typically maintained in a hyperactive state. 16, 27 However, the cells that initially activate these components are not well defined, and many studies disagree as to which molecular markers can be used to classify the degree of cellular atypia associated with PanIN and PDA formation. These differences could reflect the difficulty in comparing molecular signatures across individual patients or species, or they could reflect normal variations in different cell types.
To identify the signaling pathway signatures that define acinar-ductal metaplastic structures and early mPanIN lesions, we examined adjacent sections of LSLKras
Cre/ϩ pancreata for expression of EGFR, Mist1, and pErk to determine whether mPanINs and aci- (Figure 4 , A-C). In contrast, acinar-ductal metaplastic structures coexpressed pErk, EGFR, and Mist1, but in mosaic patterns. EGFR-positive cells undergoing acinar-ductal metaplasia were typically differentiated acinar cells that were Mist1-positive but pErk-negative, whereas Mist1-negative cells expressed high levels of nuclear pErk (Figure 4, D-F) . Adjacent normal acinar cells, although Mist1-positive, did not express detectable levels of EGFR or pErk (data not shown). Likewise, normal duct cells remained EGFR-and pErk-negative (data not shown).
These results suggest that metaplastic acinar cells may progress to duct-like cells by transitioning from Mist1
ϩ / EGFR ϩ to Mist1 Ϫ /EGFR Ϫ /pErk ϩ cells. Interestingly, we rarely observed the previously reported EGF signaling heterogeneity described for mPanIN lesions. 15 Instead, heterogeneous expression of EGFR and pErk was mostly observed in acinar-ductal metaplastic areas that were closely associated with PanINs. Here, the Mist1 Ϫ /EGFR Ϫ / pErk ϩ acinar-ductal metaplastic cells exhibited identical molecular signatures to those found in mPanIN lesions.
The EGFR/pErk expression profiles were surprising because elevated levels of EGFR in metaplastic acinarductal cells did not immediately generate the predicted activation of the downstream MAPK pathway (pErk). MAPK activity was detected only in mPanIN ductal cells or in acinar-ductal metaplastic cells that exhibited a ductlike cell phenotype. One possibility for the absence of MAPK activity in EGFR-positive cells could be that EGFR was inactive. However, this seems unlikely because LSLKras G12D/ϩ /p48 Cre/ϩ pancreata contained elevated levels of phospho-EGFR protein ( Figure 4K ).
To evaluate other members of the EGF receptor family, we next examined ErbB2 expression. As shown in Figure  4H , acinar metaplastic units universally expressed elevated levels of cytoplasmic ErbB2 protein. However, accumulation of nuclear ErbB2 was restricted to the ductal component of acinar-ductal metaplasia, and this nuclear expression was inversely correlated with EGFR (and Mist1) expression (Figure 4, G and H) . Nuclear ErbB2 has been shown to be hyperphosphorylated 28 and to function as a transactivator of cancer-related genes, 29 and immunoblots confirmed the elevated levels of phospho-ErbB2 in LSL-Kras G12D/ϩ /p48 Cre/ϩ samples ( Figure 4L ). Thus, ErbB2-mediated signaling is likely different in the acinar and ductal components of acinar-ductal metaplasia. As predicted, mPanINs exhibited the same cytoplasmic and nuclear ErbB2 expression pattern (Figure 4 , I and J). We conclude that EGF pathway signatures define individual metaplastic acinar and duct cell properties.
Early mPanIN Lesions Exhibit Acinar Cell Properties
The early appearance of acinar-ductal metaplasia in LSL-Kras G12D/ϩ /p48 Cre/ϩ pancreata and the identical molecular signature of the ductal component within 
/p48
Cre/ϩ pancreas samples were stained with antibodies to EGFR, pErk, and Mist1. EGFR and pErk exhibit opposite expression patterns in mPanIN lesions where Mist1-positive PanIN cells are EGFR-negative but pErk-positive. G: H&E staining of a large mPanIN lesion that is associated with areas of acinar-ductal metaplasia. Arrows indicate areas where acinar metaplasia is part of the mPanIN epithelial cell layer. H and I: Acinar-ductal/mPanIN hybrid structures from a 4-week LSL-Kras
Cre/ϩ pancreas. These structures have properties that are common to both acinar-ductal metaplasia and mPanINs and are composed of both duct-like cells and acinar cells. The arrows point to several acinar cells (zymogen-positive) that are within these early acinar-ductal/mPanIN-1 hybrid structures.
these lesions to mPanIN-1 structures prompted us to examine the possibility that acinar cells contributed to mPanINs in these animals. Centrally located mPanIN-1 structures were composed of columnar cells with basally located nuclei and abundant supranuclear mucin. As expected, most of the mPanIN cells were Ki67-positive, indicative of their proliferative potential (Figure 5, A and B) . However, single cells within these structures often remained Ki67-negative. The Ki67-negative cells invariably exhibited acinar cell properties, including the presence of eosin-reacting zymogen granules ( Figure 5, A and B, insets) . High-resolution immunofluorescence also revealed individual biphenotypic mPanIN cells that coexpressed both K19 and amylase ( Figure 5C ). When we examined the expression of EGFR, pErk, and Mist1, the Mist1-positive mPanIN acinar cells were EGFR ϩ /pErk Ϫ ( Figure 5 , D-F), reflecting the previously described mPanIN molecular heterogeneity. 15 Thus, the presence of metaplastic acinar cells within mPanIN-1 lesions accounts for mPanIN heterogeneity.
The results described above confirmed that acinarductal metaplasia and early mPanIN lesions exhibit similar cellular and molecular properties. Examination of LSL-Kras G12D/ϩ /p48 Cre/ϩ pancreata uncovered many areas where acinar-ductal metaplastic structures were in direct association with well-developed mPanINs ( Figure  5G ). In these examples, the duct-like cells within metaplastic structures were clearly part of the mPanIN epithelial cell layer, demonstrating that acinar cells become incorporated into pre-exiting mPanIN structures or that acinar-ductal metaplasia progresses to produce mPanIN lesions. Although we cannot distinguish between these alternative pathways at this time, hybrid acinar metaplasia/mPanIN-like structures that exhibited properties of both cell types were often observed in early LSLKras G12D/ϩ /p48 Cre/ϩ mice ( Figure 5 , H and I), raising the possibility that acinar cells undergoing acinar-ductal transitions have a significant role in mPanIN formation and PDA development.
Discussion
PDAs develop from histologically and genetically wellcharacterized precursor lesions, the PanINs. PanIN lesions usually harbor molecular alterations that include activating or inactivating mutations in the KRAS, p16
Ink4a , p19
Arf , and p53 genes. [5] [6] [7] 14 The morphological and molecular signatures associated with PanINs and PDA suggest that duct cells are responsible for these lesions, but it remains unknown if other pancreatic cell types (acinar, islet, or stem cells) might also contribute to the pathogenesis of this disease.
To examine which cells are involved in these events, we focused our efforts on the initial morphological alterations that developed after Cre/ϩ mice were highly proliferative and exhibited activated EGF signaling pathways that were differentially associated with cells exhibiting an acinar or duct cell phenotype. Single cell analysis revealed mosaic patterns of EGFR, ErbB2, and pErk protein accumulation such that EGFR was expressed in early metaplastic acinar cells that exhibited acinar cell characteristics whereas nuclear ErbB2 and pErk expression was restricted to the duct-like cells. The mosaic expression pattern of these markers was reminiscent of previous studies showing that mPanINs consisted of a heterogeneous cell population. 13, 15 Although the basis for the PanIN cell heterogeneity is not known, our results suggest it is attributable to the presence of acinar cells within mPanINs.
The fate of acinar cells within mPanINs remains elusive. Although these cells do not maintain a differentiated acinar phenotype, there is no evidence for acinar-restricted cell death within early mPanIN structures (unpublished results). Instead, we propose that acinar-ductal metaplastic structures participate in the formation of mPanIN lesions and that the participating acinar cells undergo an acinar-ductal conversion as mPanINs progress from mPanIN-1 3 mPanIN-3 ( Figure 6 ). In this model, acinar cells activate a molecular switch where acinar gene products are repressed, and metaplastic ductal gene products are expressed. A key event in this conversion is activation of the Notch signaling pathway and expression of the Notch downstream target genes Hes1, Hey1, and Hey2. Notch activity is known to prevent acinar cell differentiation, 31 and Notch is required for the tumor-initiating effects of TGF-␣. 16 Thus, mPanIN acinar cells ultimately activate the Notch signaling pathway to initiate an acinar-ductal metaplasia regulatory cascade. Once activated, the cells become highly proliferative as they expand into mPanINs and ultimately into PDA. This molecular switch may also occur in the human condition because acinar-ductal metaplasia is often associated with human PanIN lesions. 19, 20 One prediction of our model is that biphenotypic cells consisting of acinar and duct cell markers should be found within metaplastic structures. Indeed, individual cells that coexpress acinar (Mist1, amylase) and mPanIN duct (Hes1, K19) gene products have been identified, reflecting a possible transition phase as the cells adopt a ductal phenotype. Biphenotypic cells have also been reported in acinar cells undergoing transdifferentiation in TGF-␣-treated three-dimensional cultures. 30 Interest- Cre/ϩ mice. Another possibility is that metaplastic structures originate from adult progenitor cells (or a reserve cell population) that might be sensitive to Kras G12D signaling. In this instance, Kras G12D could activate a proliferation program and alter specific terminal differentiation pathways so that a subset of cells progress toward a duct cell phenotype, other cells progress toward an acinar cell phenotype, and still others exhibit aspects of both differentiated lineages (biphenotypic). Eventually, the duct cell phenotype would dominate and PanIN and PDA lesions would be produced. In this model, the LSL-Kras G12D locus would be activated in the specific progenitor or reserve cell population. Both p48
Cre/ϩ and pdx1-Cre are expressed early in pancreas development (ϳE9.5), before commitment of individual pancreas lineages, and studies using the RO-SA26 reporter line have shown that all acinar, duct, and islet cells in newborn mice contain the Cre-mediated recombined locus. 10, 12 Thus, early expression of Cre from either locus would likely activate LSL-Kras G12D in a quiescent progenitor cell population as well. In this regard, the LSL-Kras G12D/ϩ /p48 Cre/ϩ model does not perfectly mimic the human condition because all LSLKras G12D/ϩ /p48 Cre/ϩ pancreas cells contain an activated Kras allele, whereas only a small population of cells likely acquires the Kras G12D mutation in humans. Thus, caution needs to be exercised when extrapolating data from mouse models to patients. Nonetheless, our studies have shown that pancreas samples from PDA patients also exhibit acinar-ductal metaplastic structures that contain both acinar and duct cell phenotypes. Future lineage-tracing studies in mice will be required to fully investigate the ability of mature acinar cells or other cell types (duct, stem, reserve) to participate in mPanIN and PDA development. Toward this goal, we are generating inducible Mist1-Cre mouse lines that will allow us to test the importance of acinar cells to PDA development and to determine the fate of individual cells as mPanINs progress to metastatic PDA. The identification of the initiating cells will be an important advancement for early diagnostics and targeted therapeutic approaches to battle this disease.
Note
In agreement with our study, Guerra et al 34 recently demonstrated that expression of endogenous Kras G12V in acinar/centroacinar cells generates PanIN and invasive PDA through a possible acinar-ductal metaplasia pathway. 
